Biocon Limited

BSE : 532523 | NSE : BIOCON

Industry : Pharmaceuticals | ISIN : INE376G01013 | FreeFloat : 40.00% | FnO : Yes | LotSize : 2300


Intellectual Capital (IC)7,209.92
Net Worth (NW)7,383.10
Intrinsic Worth (IW)14,593.02
Market Cap (MC)32,466.00
Economic Value Added-200.45
Discount Rate%
Liquidity Premium%
Knowledge Basis (IC/IW)49.41%
IC Gross Margin (EBITDA/IC)28.44%
IC Net Margin (NPT/IC)12.68%
Knowledge Turnover (Sales/IC)0.98
Market to Intrinsic Value (MC/IW)2.22

As OfIntrinsic ValueMarket Price
31 Mar 2020Rs. 121.61Rs. 270.55
26 May 2020 - Rs. 358.30
Fundamental - medium termTechnical - near termCombined outlook
EVA > 0 : NoSell10 DMA : Rs. 342.30BuyHold
KB > 50% : No50 DMA : Rs. 321.07
0 < M2IV < 1 : NoVol-Price trend : Rising

Question 3 - Is this stock undervalued?


Question 2 - Does this business have significant knowledge assets?


Question 1 - Is this business generating enough profits to cover its cost of capital?

* EVA is a registered trademark of Stern Stewart and Co.

Quarterly Results (Rs. Cr)
Quarter
Type*
Sales
Income
EBITDA
EBIT
PBT
PAT
NPT
Jun-17
C
933.70
987.70
250.20
151.40
135.30
81.30
101.20
Sep-17
C
968.60
1019.40
239.00
145.40
131.60
89.10
95.20
Dec-17
C
1057.90
1091.80
261.80
164.40
149.70
91.90
143.60
Mar-18
C
1169.50
1237.00
305.60
210.30
193.40
130.40
128.40
Jun-18
C
1123.80
1192.60
307.10
208.00
190.40
119.70
41.00
Sep-18
C
1321.00
1375.40
581.90
469.70
450.90
354.70
317.10
Dec-18
C
1540.80
1566.40
424.60
307.90
289.30
217.20
288.60
Mar-19
C
1528.80
1557.00
420.00
300.20
284.30
213.70
283.50
Jun-19
C
1465.90
1490.00
453.70
329.50
312.90
227.70
206.30
Sep-19
C
1572.20
1610.60
509.30
377.70
353.90
215.70
206.80
Dec-19
C
1748.10
1783.90
476.80
332.80
315.10
202.80
235.50
Mar-20
C
1581.00
1644.10
373.30
220.90
204.10
123.40
72.10
* C - Consolidated, S - Standalone